Skip to main content

Follow the Money

In 2024, pharmaceutical and medical-device companies paid $2.45B to 948,323 US doctors across 14.3M individual payments. Every dollar disclosed by federal law.

Total Paid

$2.5B

Companies

1557

Doctors Paid

4.2M

Payment Records

14.3M

Open Payments is the federal transparency program created by the Physician Payments Sunshine Act. Every pharmaceutical and medical-device manufacturer must report what they paid to US doctors, and CMS publishes the file. In program year 2024, just 10 companies account for 35.5% of all industry-to-physician dollars, and three payment categories (consulting, royalty, acquisitions) carry 47.1% of the money on 1.28% of the records. This page turns 14.3M records into patterns you can scan.

The Biggest Payers

Top 15 companies by total dollars paid to US doctors, 2024.

AbbVie leads the 2024 file at $150.3M paid to 226,167 doctors, with BOTOX as the top-named product. Stryker follows at $113.3M to 28,695 recipients, then Medtronic at $112.9M tied to its CD HORIZON spinal system. The ranked top 20 captures the bulk of industry-to-physician dollar flow in the country. Concentration is a feature of this dataset, not an anomaly.

#1

ABBVIE INC.

226,167 doctors · 1,718,115 payments · Top product: BOTOX

$150.3M
#2

Stryker Corporation

28,695 doctors · 144,896 payments · Top product: ACCOLADE

$113.3M
#3

Medtronic, Inc.

77,038 doctors · 340,707 payments · Top product: CD HORIZON SPINAL SYSTEM

$112.9M
#4

Arthrex, Inc.

4,760 doctors · 49,301 payments · Top product: Arthrex

$103.8M
#5

Edge Endo LLC

9 doctors · 11 payments · Top product: EdgePRO

$91.1M
#6

Zimmer Biomet Holdings, Inc.

7,771 doctors · 32,574 payments · Top product: Avenir

$82.5M
#7

INTUITIVE SURGICAL, INC.

16,235 doctors · 115,646 payments · Top product: Da Vinci Surgical System

$59.9M
#8

AstraZeneca Pharmaceuticals LP

136,862 doctors · 607,915 payments · Top product: AIRSUPRA

$56.0M
#9

DePuy Synthes Products, Inc.

357 doctors · 2,541 payments · Top product: ATTUNE

$50.2M
#10

Boston Scientific Corporation

68,994 doctors · 263,324 payments · Top product: WATCHMAN Access System

$49.0M
#11

Smith+Nephew, Inc.

23,673 doctors · 70,726 payments · Top product: EVOS

$43.7M
#12

Lilly USA, LLC

121,191 doctors · 534,620 payments · Top product: MOUNJARO

$40.7M
#13

Amgen Inc.

118,337 doctors · 472,993 payments · Top product: Otezla

$40.3M
#14

GENZYME CORPORATION

48,415 doctors · 181,426 payments · Top product: DUPIXENT

$37.1M
#15

Abbott Laboratories

74,229 doctors · 291,208 payments · Top product: FREESTYLE LIBRE 3

$34.1M

The top 10 companies combined paid $869M, or 35.5% of every industry-to-physician dollar in 2024. That concentration reflects who writes the biggest checks: a handful of large pharma and orthopedic-device manufacturers. Click any company for per-state breakdowns and the full top-recipient table.

How Doctors Get Paid

Payment types ranked by total dollars. Record count tells a different story than dollars.

Food and Beverage is the most common payment type by a wide margin: 13.2M records at an average of $29 per meal. But meals do not lead the dollar column. Speaking and faculty compensation tops total spend at $537.8M, followed by Consulting at $498.8M and Royalty or License at $447.8M. Royalty has only 10,563 records in the whole year, but averages $42,397 per payment, with one royalty check reaching $9.15M.

Speaking / faculty compensation

218,157 payments · avg $2K

22%$537.8M

Consulting Fee

171,991 payments · avg $3K

20.4%$498.8M

Royalty or License

10,563 payments · avg $42K

18.3%$447.8M

Food and Beverage

13,181,728 payments · avg $29

15.6%$383.3M

Acquisitions

411 payments · avg $507K

8.5%$208.4M

Travel and Lodging

548,029 payments · avg $344

7.7%$188.3M

Education

142,317 payments · avg $404

2.3%$57.5M

Honoraria

13,224 payments · avg $3K

1.5%$36.4M

Speaking / faculty compensation

13,388 payments · avg $2K

1.3%$30.8M

Grant

3,490 payments · avg $8K

1.1%$27.8M

Debt forgiveness

2,294 payments · avg $8K

0.8%$18.8M

Long term medical supply or device loan

10,533 payments · avg $1K

0.4%$11.0M

Gift

14,567 payments · avg $179

0.1%$2.6M

Entertainment

6,153 payments · avg $96

0%$591K

Charitable Contribution

143 payments · avg $1K

0%$185K

Consulting, royalty, and acquisitions combined reach $1.16B, which is 47.1% of all dollars on just 1.28% of records. That is the premium tier. The Food and Beverage column is where the reach sits, since most of the 948,323 paid doctors touch the program through a meal. The premium tier is where the real money sits.

What the Data Shows

Six patterns from 14.3 million payment records. Each number traces to Open Payments.

One payment equals 3.1 million meals

Charles Goodis, an endodontist in Florida, received a single payment of $91,082,706 from Edge Endo LLC in 2024. The average Food and Beverage payment in Open Payments runs $29. At that rate, one check to one dentist equals 3.1 million meals to 3.1 million other doctors.

Three categories hold 47% of the money on 1.3% of the records

Consulting, royalty, and acquisitions combined reach $1.16B, which is 47.1% of all industry-to-physician dollars in 2024. That sits on just 182,965 records, or 1.28% of the 14.3M total. Food and Beverage is the reverse: 13.2M records (92% of the count) but only 15.6% of the dollars.

Orthopedic surgeons draw 22x what internists draw per head

Orthopaedic Surgery averages $21,382 per doctor in 2024. Internal Medicine averages $978. Cardiovascular Disease sits between at $2,977. The gap reflects where device royalties and consulting contracts land: on implantable-device specialties rather than on general primary care.

Endodontists top the per-doctor table

Only 1,770 endodontists appear in Open Payments for 2024, but they collectively received $102.2M. That is $57,719 per doctor, higher than any surgical specialty. Dental-implant and endodontic-biomaterial royalties concentrate on a small inventor group, and one payment of $91.1M accounts for most of the pot.

AbbVie leads: $150M to 226,167 doctors

AbbVie paid $150.3M to 226,167 US doctors across 1.7M individual payments in 2024, with BOTOX as the top-named product. That is the broadest industry footprint in the dataset. Stryker ranks second at $113.3M but reaches only 28,695 recipients, a classic device-company pattern of fewer doctors and bigger checks.

Top 10 companies hold 35.5% of every dollar

The top 10 companies paid $869M, which is 35.5% of the $2.45B total. 1,547 other companies split the remaining 64.5%. Concentration on the company side mirrors concentration on the doctor side: the top 10 recipients captured 9.3% of all industry-to-physician dollars in 2024.

Most Targeted Specialties

Top 12 specialties by total dollars received. Per-doctor rate shown alongside.

Orthopaedic Surgery leads total dollars at $363.7M across 17,012 doctors, or $21,382 per doctor, driven by device royalties and consulting contracts on joints, spine implants, and instruments. But the per-doctor leader is a dental specialty: 1,770 endodontists received $102.2M, or $57,719 each. Total dollars and per-doctor dollars tell different stories.

Orthopaedic Surgery

17,012 doctors · $21K per doctor

$363.7M

Internal Medicine

109,931 doctors · $978 per doctor

$107.5M

Endodontics

1,770 doctors · $58K per doctor

$102.2M

Neurology

13,508 doctors · $6K per doctor

$85.5M

Dermatology

12,845 doctors · $6K per doctor

$79.0M

Cardiovascular Disease

23,092 doctors · $3K per doctor

$68.8M

Neurological Surgery

5,243 doctors · $13K per doctor

$68.4M

Psychiatry

13,918 doctors · $5K per doctor

$65.4M

Surgery

19,993 doctors · $3K per doctor

$62.3M

Gastroenterology

14,467 doctors · $4K per doctor

$60.8M

Hematology & Oncology

10,842 doctors · $6K per doctor

$60.5M

Family

100,741 doctors · $538 per doctor

$54.2M

Device-heavy specialties (orthopedic surgery, neurological surgery, cardiology) draw royalty and consulting dollars from implant manufacturers. Primary-care specialties draw high-volume, low-dollar meals and education: Internal Medicine averages $978 per doctor and Family nurse practitioners average $538. Orthopaedic Surgery's $21,382 per doctor runs roughly 22x what internal medicine pulls per head.

Where the Money Lands

Top 10 states by total dollars paid to doctors in the state.

Florida leads all states at $277.6M paid to 81,972 doctors, edging California at $271.4M to 93,842 doctors. Per doctor, Florida runs $3,386 against California's $2,892. The biggest total is not always the biggest per-doctor rate.

#1

FL

81,972 doctors · $3K per doctor

$277.6M
#2

CA

93,842 doctors · $3K per doctor

$271.4M
#3

TX

84,013 doctors · $2K per doctor

$188.5M
#4

NY

69,169 doctors · $3K per doctor

$180.9M
#5

PA

44,760 doctors · $2K per doctor

$98.8M
#6

IL

38,571 doctors · $3K per doctor

$97.2M
#7

OH

40,427 doctors · $2K per doctor

$86.1M
#8

NC

33,990 doctors · $2K per doctor

$81.0M
#9

TN

25,621 doctors · $3K per doctor

$75.2M
#10

VA

25,409 doctors · $3K per doctor

$73.2M

Per-doctor differences reflect specialty mix. Florida's concentration of orthopedic surgeons, sports-medicine clinics, and dental specialists pulls its average up. Texas is the third-biggest pot at $188.5M but runs at just $2,243 per doctor across a much broader base.

The Top 10 Recipients

Individual doctors receiving the largest payment totals in 2024. Open Payments requires disclosure by name.

Charles Goodis, an endodontist in Florida, received $91,082,706 in a single payment in 2024, making him the country's #1 recipient. Robert Medoff, an orthopedic surgeon in Hawaii, is second at $26.7M, also from a single payment. These are public records. The Sunshine Act requires full transparency, including names. The distribution is a tiny peak, not a broad tail.

The top 10 doctors combined captured $227M, or 9.3% of all industry-to-physician dollars. Royalty and acquisition deals on patented devices concentrate money on a small group of inventors, not on general clinicians.

Browse All Companies

Search 1557 reporting companies, or scroll the ranked list. Click any company for state breakdown, top recipients, and product detail.

#1ABBVIE INC.$150.3M226,167 docs#2Stryker Corporation$113.3M28,695 docs#3Medtronic, Inc.$112.9M77,038 docs#4Arthrex, Inc.$103.8M4,760 docs#5Edge Endo LLC$91.1M9 docs#6Zimmer Biomet Holdings, Inc.$82.5M7,771 docs#7INTUITIVE SURGICAL, INC.$59.9M16,235 docs#8AstraZeneca Pharmaceuticals LP$56.0M136,862 docs#9DePuy Synthes Products, Inc.$50.2M357 docs#10Boston Scientific Corporation$49.0M68,994 docs#11Smith+Nephew, Inc.$43.7M23,673 docs#12Lilly USA, LLC$40.7M121,191 docs#13Amgen Inc.$40.3M118,337 docs#14GENZYME CORPORATION$37.1M48,415 docs#15Abbott Laboratories$34.1M74,229 docs#16Janssen Biotech, Inc.$29.7M49,642 docs#17E.R. Squibb & Sons, L.L.C.$28.6M63,463 docs#18PFIZER INC.$28.5M128,131 docs#19Henry Schein, Inc.$26.7M2 docs#20Novo Nordisk Inc$25.3M110,476 docs#21GlaxoSmithKline, LLC.$25.0M87,135 docs#22Regeneron Healthcare Solutions, Inc.$24.0M46,881 docs#23Edwards Lifesciences Corporation$22.6M19,425 docs#24Alphatec Spine, Inc$22.3M1,295 docs#25Gilead Sciences, Inc.$21.9M29,912 docs#26ENCORE MEDICAL, LP$19.8M650 docs#27Medical Device Business Services, Inc.$19.7M7,248 docs#28LivaNova USA, Inc.$19.4M3,015 docs#29Merck Sharp & Dohme LLC$18.6M96,248 docs#30CSL Plasma Inc.$17.6M258 docs#31Align Technology, Inc.$16.7M21,796 docs#32UCB, Inc.$16.2M26,230 docs#33Boehringer Ingelheim Pharmaceuticals, Inc.$16.0M74,604 docs#34Takeda Pharmaceuticals U.S.A., Inc.$16.0M45,129 docs#35Janssen Pharmaceuticals, Inc$14.9M59,451 docs#36Novartis Pharmaceuticals Corporation$14.5M84,754 docs#37Otsuka America Pharmaceutical, Inc.$14.2M54,582 docs#38Teva Pharmaceuticals USA, Inc.$13.8M30,295 docs#39Bausch & Lomb Americas Inc.$13.4M25,118 docs#40Neurocrine Biosciences, Inc.$13.4M25,250 docs#41Incyte Corporation$12.4M20,024 docs#42Axsome Therapeutics, Inc.$12.2M27,126 docs#43Alcon Vision LLC$11.7M28,106 docs#44AngioDynamics, Inc.$10.8M4,630 docs#45ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)$10.8M29,310 docs#46Phathom Pharmaceuticals, Inc.$10.6M35,618 docs#47Astellas Pharma US Inc$10.4M60,618 docs#48Dentsply Sirona Inc$10.1M19,350 docs#49Alkermes, Inc.$10.0M21,278 docs#50Alexion Pharmaceuticals, Inc.$9.9M18,730 docs#51EMD Serono, Inc.$9.4M9,285 docs#52ABIOMED$8.9M22,921 docs#53Bayer Healthcare Pharmaceuticals Inc.$8.8M54,916 docs#54SANOFI-AVENTIS U.S. LLC$8.7M22,622 docs#55ViiV Healthcare Company$8.5M9,672 docs#56ConvaTec Inc.$8.4M6,401 docs#57MEDACTA USA, INC.$8.4M1,004 docs#58SI-BONE, INC.$8.1M5,475 docs#59JAZZ PHARMACEUTICALS INC.$8.1M12,478 docs#60Regeneron Pharmaceuticals, Inc.$7.7M1,613 docs#61Genentech USA, Inc.$7.6M21,607 docs#62Asklepios Biopharmaceutical Inc.$7.6M11 docs#63EXACTECH, INC.$7.4M582 docs#64Straumann USA LLC$7.2M15,342 docs#65Skye Orthobiologics LLC$7.2M36 docs#66TREACE MEDICAL CONCEPTS, INC.$7.1M3,590 docs#67Inari Medical, Inc.$7.1M15,178 docs#68Eisai Inc.$6.4M18,051 docs#69Alcon Research LLC$6.4M263 docs#70ShockWave Medical, Inc$6.3M6,695 docs#71VERTEX PHARMACEUTICALS INCORPORATED$6.3M8,352 docs#72Envista Holdings Corporation$6.0M8,476 docs#73Highridge Medical LLC$5.7M911 docs#74Philips North America LLC$5.6M18,604 docs#75ZIMVIE INC.$5.6M12,925 docs#76Penumbra, Inc.$5.6M6,368 docs#77Eli Lilly and Company$5.5M959 docs#78Daiichi Sankyo Inc.$5.3M19,581 docs#79Arcutis Biotherapeutics, Inc.$5.0M9,749 docs#80Teleflex LLC$5.0M7,993 docs#81Biogen, Inc.$5.0M11,916 docs#82W. L. Gore & Associates, Inc.$4.9M7,254 docs#83ATRICURE, INC.$4.9M9,730 docs#84Pacira Pharmaceuticals Incorporated$4.7M10,671 docs#85TG Therapeutics, Inc.$4.7M3,110 docs#86SUN PHARMACEUTICAL INDUSTRIES INC.$4.6M21,772 docs#87Linvatec Corporation$4.6M1,281 docs#88Vanda Pharmaceuticals Inc.$4.5M13,380 docs#89Cook Incorporated$4.5M401 docs#90Alnylam Pharmaceuticals Inc.$4.4M9,666 docs#91Organon Llc$4.4M23,655 docs#92CSL Behring$4.4M10,333 docs#93Supernus Pharmaceuticals, Inc.$4.4M14,937 docs#94Actelion Pharmaceuticals US, Inc.$4.4M11,525 docs#95Salix Pharmaceuticals, a division of Bausch Health US, LLC$4.2M42,040 docs#96Ipsen Biopharmaceuticals, Inc$4.2M9,749 docs#97Glaukos Corporation$4.0M5,795 docs#98Siemens Medical Solutions USA, Inc.$4.0M3,752 docs#99Janssen Scientific Affairs, LLC$4.0M5,857 docs#100Solventum Corporation$3.9M16,960 docs

Frequently Asked Questions

What Open Payments is, and why these numbers exist.

What is the Open Payments program?

Open Payments is the federal transparency database maintained by the Centers for Medicare and Medicaid Services (CMS). The Physician Payments Sunshine Act, passed in 2010, requires pharmaceutical and medical-device manufacturers to report every payment or transfer of value they give to US physicians and teaching hospitals. The full file is public and searchable by company, specialty, state, and recipient.

Are these payments illegal?

No. Federal law permits consulting fees, speaking honoraria, royalty payments on patented devices, research funding, meals, and travel reimbursement between industry and physicians. The Sunshine Act does not restrict these payments. It requires that they be disclosed, so patients and researchers can see the relationships.

How much did companies pay US doctors in 2024?

Industry reported $2.45B paid to 948,323 US doctors across 14.3M individual payments in program year 2024, coming from 1,557 pharmaceutical and medical-device manufacturers. That reaches roughly 94.8% of all actively practicing physicians in the country.

Which payment type is most common by count? By dollars?

By count, Food and Beverage dominates: 13.2M records at an average of $29 per meal. By dollars, Speaking and faculty compensation leads at $537.8M, followed closely by Consulting at $498.8M and Royalty or License at $447.8M. The count and dollar columns tell very different stories.

Why are some single-doctor payments so large?

Most of the very large single-recipient figures are royalty or acquisition payments tied to patented medical devices. A surgeon or dentist who co-invented an implant, instrument, or biomaterial receives royalties on every unit sold, or a lump sum when the company buys out those rights. Charles Goodis, an endodontist in Florida, received $91,082,706 in a single 2024 payment from Edge Endo LLC tied to endodontic products.

Methodology & Sources

How this page was built and what it includes.

How it worksData comes from the CMS Open Payments program, which aggregates mandatory disclosures from pharmaceutical and medical-device manufacturers under the Physician Payments Sunshine Act. Program year 2024 is the latest complete annual file. It includes general payments (meals, consulting, speaking, travel, education, royalty, acquisitions) and research payments reported at the physician level. Payments to teaching hospitals as entities are excluded from these totals.
SourcesCMS Open Payments program (openpaymentsdata.cms.gov). Company-level aggregates built from the provider_payments fact table covering 14.3M rows for program year 2024.
LimitsProgram year 2024 is the latest complete year available. Company aggregation rolls up subsidiaries under the reported legal name, so some parents and subsidiaries may appear as separate lines (for example, Janssen entities and Johnson & Johnson subsidiaries). Very small payments below federal reporting thresholds are not captured. NPI-linked physicians only; payments to non-physician professionals and to hospitals are excluded here.
Update cadenceCMS releases Open Payments data annually in June for the prior calendar year.